Tacrozemus Ointment 0.3% 10g
0.3% 10gDermatitis

Tacrozemus

Tacrozemus Ointment 0.3% 10g

Tacrolimus

Hiranis Pharmaceuticals (Pvt) Limited pc 1 units

Drug Identity

Active Ingredient
Tacrolimus
Drug Class
Antipsoriatics
ATC Code
D11AH01, L04AD02
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Safety Alerts

Application to malignant or potentially malignant skin lesions, application under occlusion, avoid contact with eyes and mucous membranes, congenital epidermal barrier defects, generalized erythroderma, immunodeficiency, infection at treatment site, pregnancy, lactation, hypersensitivity to macrolides

Important Warnings

Hepatic failure, avoid exposure to UV light
Treat infections before therapy
Monitor patients who develop lymphadenopathy

Side Effects

Application-site paininfections and reactionsherpes simplex infectionlocal irritationKaposis varicelliform eruptionacne. Rare: cutaneous lymphomaother types of lymphomasrosaceaskin malignancy

Drug Interactions

Avoid use of emollients within 2 hours
CYP3A4 inhibitors in widespread or erythrodermic disease
vaccines.

Price Intelligence

Rs 403.76
DVAGO observed price · as of 30 July 2026
Rs 403.76 per unit
No approved ceiling matched to this exact pack and strength.
Prices across sources
DVAGORs 403.76

Should you consider an alternative?

Other options containing Tacrolimus, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.